Capnostics (Acquired by PAVmed)

www.businesswire.com
Innovation Type:
Medical Technologies
Cancer Type:
Other
Funding Stage:
Proof of Concept
Fund:
Prospects
CellMate product for esophageal cell sampling for early detection in patients at high risk of esophageal adenocarcinoma

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.